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Nonconvulsive status epilepticus (NCSE) is a severe medical condition that shows increased incidence in the elderly and is fre-
quentlyunderdiagnosedbecauseofitspleomorphicpresentation.WereportanNCSEina76-year-oldwomanaﬀectedbydementia
with acute change of cognitive status and behavior. Intravenous diazepam solved clinical and electroencephalographic manifes-
tations. Neuropsychological assessment after NCSE conclusion showed impairment of several ﬁelds that remained unchanged at
3-month followup. NCSE should be considered when sudden and transient cognitive ﬂuctuations appear in the elderly. Epileptic
events in dementia occur frequently and are often underrecognized; this could be a misleading factor when considering a quick
progression of mnesic performances. Moreover, recent ﬁndings both in animal models and in humans demonstrated the deep link
betweenepilepsyanddementia,alsosupportingthehypothesisthatepileptiformactivitycouldcontributetocognitiveimpairment.
1.Introduction
Epileptic events, even a status epilepticus (SE), should be
considered when ﬂuctuations of cognition and awareness
occur in elderly people, especially if dementia coexists [1, 2].
In particular, the nonconvulsive status epilepticus (NCSE) is
a pleomorphic condition, usually underdiagnosed, deﬁned
bytheassociationofchangesinconsciousnesswithoutmajor
motorsignsandcontinuousorrepeatedepilepticdis-charges
beyond 30 minutes on EEG [3]. It appears most often as
clinical confusion, corresponding either to absence status
(AS) or complex partial status epilepticus (CPSE) [4–9].
According to experimental and clinical observations that
focal epileptic activity tends to generalize less often in old
age,elderlypeopleshowanincreasedincidenceofNCSE—in
particular acute symptomatic CPSE—especially in associa-
tion with neurodegenerative, cerebrovascular, or neoplastic
disorders [1, 4–6, 10].
Furthermore, several clinical and experimental data
supportacloselinkagebetweenpathophysiologicalprocesses
sustainingepilepsyandcognitiveimpairmentofdementia.In
fact, both the ictal and postictal eﬀects of the seizures them-
selves and the eﬀects of the interictal epileptiform EEG dis-
charges may have an impact on cognition [11]; on the other
hand, patients with Alzheimer disease (AD) and other types
of dementias are at 5–10 fold increased risk of epilepsy com-
pared to age-matched controls [12]. Finally, β-amyloid was
recently demonstrated to favour epileptiform activity and
cognitive deﬁcits in transgenic mouse models of AD [13, 14].
We report an NCSE in a 76-year-old woman aﬀected by
dementia.
2.CaseReport
A 76-year-old woman was admitted to our department
complaining of an acute worsening of cognitive status and
a ﬂuctuating level of consciousness. One year ago, she
received a diagnosis of dementia. She has also been suﬀer-
ing from recurrent complex partial seizures for 15 years,
and she was taking two antiepileptic drugs (valproicacid,
1000mg/die and oxcarbazepine, 600mg/die); the monthly
seizure frequency was two. Moreover, she was suﬀering
from hypertension and depression and received several
medications (ticlopidine, sartan/hydrochlorothiazide 50 +
12.5mg, paroxetine 20mg/die). Finally, in her history, there
was a nonspeciﬁed cerebrovascular accident 16 years ago.2 International Journal of Alzheimer’s Disease
Her relatives deﬁned her actual behaviour as diﬀerent
from the usual one, and they noted a ﬂuctuating cognitive
status in the last weeks. Upon examination, she looked
distracted and vacant. She replied to questions only after a
brief pause and with inadequate answers. She had trouble
speaking, and she was uncooperative and disoriented. Some
minutes later she presented a restriction of consciousness
(ﬁxed gaze and unresponsive to any kind of stimuli) with
motor signs (oro-alimentary automatisms and jerking of
right foot) lasting some minutes. Then, only persisted
consciousness restriction.
The EEG examination that was performed during the
episode showed a subcontinuous theta-delta activity with
sporadic low-voltage spikes prevalent in the bilateral fron-
totemporal regions longer than 30 minutes from symptoms’
onset, and thus leading to the diagnosis of CPSE (Figure 1).
She was promptly given intravenous diazepam (5mg) with
resolution of clinical and electroencephalographic manifes-
tations.Afterdiazepamadministrationthepatientfellasleep.
The EEG recording revealed clear interictal epileptiform
waves on the left frontotemporal area during stage 2 NREM
sleep (Figure 2). Brain MRI performed on the fourth day
showed a T2-weighted abnormal hyperintensity in the left
insular cortex consistent with a vascular gliotic area. A severe
impairment of memory and attention with minor deﬁcits of
language and praxia were evident at the neuropsychological
assessment on the ﬁfth day after CPSE. MMSE score
was 12/30. She was discharged with an increased dose of
oxcarbazepine (1800mg/die). Neuropsychological evalua-
tion demonstrated an unchanged cognitive performance at
3-month followup.
3. Discussion
Transient events including syncope, episodes of inattention,
or confusion are frequent in elderly people, mainly in
patients aﬀected by dementia [1, 2]. In our patient, with a
known cognitive impairment, the acute change in behavior
and cognition, associated with a restriction of consciousness,
leads to the suspicion of an epileptic event. The EEG
provided evidence of an electroclinical pattern of CPSE that
explained the patient’s symptoms.
Rapid cognitive decline in demented patients could
mimic several disorders: metabolic encephalopathy, pro-
longed postictal confusion, psychiatric disorders, sub-
stance intoxication, transient global amnesia, and transient
ischemic attack [15]. NCSE should be included in the
diﬀerential diagnosis, as a potentially treatable cause of
altered awareness in the elderly. NCSE appears to have a
gradual development of symptoms (impaired consciousness;
“epileptic twilight state” with confusion, strange behavior,
and automatisms). Therefore, its identiﬁcation is usually
diﬃcult, especially when clinical manifestation only consists
of mild changes in behavior. In our patient, the presence of
preexisting epilepsy and dementia fortiﬁed the presumption
of a statusepilepticus (SE) [1,6,8,16]. Furthermore, she was
in treatment with paroxetine that reduces the seizure thresh-
old [17]. Several previous studies have demonstrated the
frequency of a delayed diagnosis of an NCSE in elderly due
totheabsenceofcertainclinicalparameters[18].Husainand
colleagues tried to deﬁne a proﬁle of clinical features highly
suggestive of NCSE (risk factors for seizures such as history
of epilepsy, dementia and stroke, and impaired mental state)
in order to select those patients who need an emergency EEG
[19]. The EEG is fundamental to obtain an early diagnosis
and should be promptly considered as a standard protocol
in acute de novo confusion in these patients with high level
of suspicion for NCSE [3]. Moreover, EEG ﬁndings are
necessary to localize the epileptic focus and to distinguish a
CPSE from an absence status, since in the ﬁrst one, a rapid
cessation is required due to prolonged episodes that may
be accompanied by neurological deﬁcits. Benzodiazepines
are the most commonly recommended agents [20, 21]. The
aims of therapy when treating NCSE are the improvement of
individual’scognitive functionandtoclearEEGtracingfrom
epileptiform discharges [6, 15]. Our patient’s critical EEG
deﬁnitely improved during treatment. No causative medical
disorders were recognized at blood test. We supposed that
the patient was aﬀected by symptomatic focal epilepsy, and
her poor antiepileptic therapy compliance in association to a
lower seizure threshold was the cause of SE.
The hypothesis of an “epileptic pseudodementia” has
been later confuted by cognitive assessment followup that
proved a stationary neuropsychological impairment. The
patient’s relatives noted a very diﬀerent behavior prior to
admission. We could hypothesize that she might have expe-
rienced some other prolonged epileptic events that were not
recognized.Animalmodelsandsomeobservationinhumans
have shown that NCSE could be responsible for long-term
deﬁcits also in neuropsychological ﬁeld. How much morbid-
ityaddsictalconfusiontoapreexistingcognitiveimpairment
remainshighlydebated.Theauthorsconﬁrmtheinﬂuenceof
causative medical disorders, the treatment, and perhaps the
persistence of seizure activity in complications and sequels
of NCSE [6, 15]. Both ictal and interictal epileptiform EEG
discharges could have an additional and independent eﬀect
on cognition. Nevertheless, some authors downsize their
role except for cryptogenic partial epilepsies that seem to
be associated with a higher risk of cognitive impairment
[22]. In our case, the left frontotemporal epileptic discharges
should be compatible with clinical features of language
and memory impairment and well match with the insular
vascular gliotic area revealed by MRI. Thus, it could be
argued that previous stroke caused the ischemic insular
lesion and then symptomatic epilepsy.
Finally, interesting recent studies have speculated on
several mechanisms that could link epilepsy to cognitive
decline and vice versa. Cordonnier and De Reuck [23,
24] reported that epileptic seizures, both early and late-
onset, after stroke were independent predictors of new-
onset dementia. They speculated that preexisting vascular
pathologies that may predispose to both epileptic seizures
and new-onset dementia could be white matter changes,
silent infarcts, or microbleeds. Alternatively, this could be
due to an underlying preclinical degenerative disorder such
as Alzheimer’s disease. The recent ﬁndings in AD animal
models of causal relationship between Aβ-induced aberrant



















Figure 1: Ictal EEG. The EEG during the episode showed a subcontinuous theta-delta activity with sporadic low-voltage spikes prevalent in



















Figure 2: EEG activity after diazepam administration. After diazepam administration, the patient fell asleep, and EEG recording showed
sharp waves on the left frontotemporal area during stage 2 NREM sleep.
the possibility that also in humans epileptiform activity
could represent a primary mechanism that may contribute
to cognitive deﬁcits [13, 25, 26]. However, the long-term
eﬀect of seizure activity on the neurodegenerative disorder is
unknown. Finally, the putative epileptogenic mechanism in
patients with combined recurrent seizures and a progressive
neurodegenerative disorder may relate to the ﬁndings of
neuronal loss and gliosis involving selected regions such as
t h em e d i a lt e m p o r a ll o b e[ 25].
4. Conclusion
Epileptic events in dementia are frequent and often under-
recognized, and this could be a misleading factor when4 International Journal of Alzheimer’s Disease
considering a quick progression of mnesic performances.
NCSE should be always considered when sudden and tran-
sient changes in behavioral or cognitive baseline condition
are presented in an elderly patient, especially if aﬀected
by dementia when there are no other evident causes. It is
mandatory to recognize the suggestive features for NCSE in
an early stage and to perform a prompt EEG to diagnose and
treat this epileptic condition.
References
[1] L. J. Stephen and M. J. Brodie, “Epilepsy in elderly people,”
Lancet, vol. 355, no. 9213, pp. 1441–1446, 2000.
[2] N.Scarmeas,L.S.Honig,H.Choietal.,“SeizuresinAlzheimer
disease:who,when,andhowcommon?”ArchivesofNeurology,
vol. 66, no. 8, pp. 992–997, 2009.
[ 3 ]F .J .B o t t a r o ,O .A .M a r t i n e z ,M .M .F .P a r d a l ,J .E .B r u e t m a n ,
and R. C. Reisin, “Nonconvulsive status epilepticus in the
elderly: a case-control study,” Epilepsia, vol. 48, no. 5, pp. 966–
972, 2007.
[4] M. Holtkamp, K. Buchheim, H. Siegmund, and H. Meierkord,
“Optical imaging reveals reduced seizure spread and propaga-
tionvelocitiesinagedratbraininvitro,”NeurobiologyofAging,
vol. 24, no. 2, pp. 345–353, 2003.
[5] J. C. DeToledo, “Changing presentation of seizures with aging:
clinical and etiological factors,” Gerontology, vol. 45, no. 6, pp.
329–335, 1999.
[6] M. Walker, H. Cross, S. Smith et al., “Nonconvulsive status
epilepticus: epilepsy research foundation workshop reports,”
Epileptic Disorders, vol. 7, no. 3, pp. 253–296, 2005.
[7] P.W. Kaplan, “Behavioral manifestations of nonconvulsive
status epilepticus,” Epilepsy and Behavior,v o l .3 ,n o .2 ,p p .
122–139, 2002.
[8] S. Haﬀey, A. McKernan, and K. Pang, “Non-convulsive
status epilepticus: a proﬁle of patients diagnosed within a
tertiaryreferralcentre,”JournalofNeurology,Neurosurgeryand
Psychiatry, vol. 75, no. 7, pp. 1043–1044, 2004.
[9] W. Lennox, “The petit mal epilepsies: their treatment with
tridione,”JournaloftheAmericanMedicalAssociation,vol.129,
pp. 1069–1073, 1945.
[10] J. L. Fern´ andez-Torre and A. G. D´ ıaz-Castroverde, “Non-
convulsive status epilepticus in elderly individuals: report of
four representative cases,” Age and Ageing,v o l .3 3 ,n o .1 ,p p .
78–81, 2004.
[11] A. P. Aldenkamp, J. Overweg, T. H. Gutter, A. M. Beun,
L. Diepman, and O. G. Mulder, “Eﬀect of epilepsy, seizures
and epileptiform EEG discharges on cognitive function,” Acta
Neurologica Scandinavica, vol. 93, no. 4, pp. 253–259, 1996.
[12] M. F. Mendez and G. T. H. Lim, “Seizures in elderly patients
with dementia: epidemiology and management,” Drugs and
Aging, vol. 20, no. 11, pp. 791–803, 2003.
[13] J. J. Palop, J. Chin, E. D. Roberson et al., “Aberrant excitatory
neuronal activity and compensatory remodeling of inhibitory
hippocampalcircuitsinmousemodelsofAlzheimer’sdisease,”
Neuron, vol. 55, no. 5, pp. 697–711, 2007.
[14] J. J. Palop and L. Mucke, “Epilepsy and cognitive impairments
in Alzheimer disease,” Archives of Neurology,v o l .6 6 ,n o .4 ,p p .
435–440, 2009.
[15] H. Meierkord and M. Holtkamp, “Non-convulsive status
epilepticus in adults: clinical forms and treatment,” Lancet
Neurology, vol. 6, no. 4, pp. 329–339, 2007.
[16] P. W. Kaplan, “The clinical features, diagnosis, and prognosis
ofnonconvulsive statusepilepticus,” Neurologist,v ol.11,no .6,
pp. 348–361, 2005.
[17] F. Pisani, G. Oteri, C. Costa, G. Di Raimondo, and R. Di Perri,
“Eﬀects of psychotropic drugs on seizure threshold,” Drug
Safety, vol. 25, no. 2, pp. 91–110, 2002.
[18] R. D. Sheth, J. F. Drazkowski, J. I. Sirven, B. E. Gidal, and B.
P. Hermann, “Protracted ictal confusion in elderly patients,”
Archives of Neurology, vol. 63, no. 4, pp. 529–532, 2006.
[19] A. M. Husain, G. J. Horn, and M. P. Jacobson, “Non-
convulsive status epilepticus: usefulness of clinical features
in selecting patients for urgent EEG,” Journal of Neurology
Neurosurgery and Psychiatry, vol. 74, no. 2, pp. 189–191, 2003.
[ 2 0 ]H .G a s t a u t ,P .T i n u p e r ,U .A g u g l i a ,a n dE .L u g a r e s i ,“ T r e a t -
mentofcertainformsofstatusepilepticusbymeansofasingle
oral dose of clobazam,” Revue d’´ Electroenc´ ephalographie et de
Neurophysiologie Clinique, vol. 14, no. 3, pp. 203–206, 1984.
[21] F. W. Drislane, “Presentation, evaluation, and treatment of
nonconvulsive status epilepticus,” Epilepsy and Behavior, vol.
1, no. 5, pp. 301–314, 2000.
[22] A. P. Aldenkamp and J. Arends, “Eﬀects of epileptiform EEG
discharges on cognitive function: is the concept of “transient
cognitive impairment” still valid?” Epilepsy and Behavior, vol.
5, supplement 1, pp. S25–S34, 2004.
[23] C. Cordonnier, H. H´ enon, P. Derambure, F. Pasquier, and D.
Leys, “Early epileptic seizures after stroke are associated with
increased risk of new-onset dementia,” Journal of Neurology,
Neurosurgery and Psychiatry, vol. 78, no. 5, pp. 514–516, 2007.
[24] J. De Reucka, M. De Clercka, and G. Van Maeleb, “Vascular
cognitive impairment in patients with late-onset seizures after
an ischemic stroke,” Clinical Neurology and Neurosurgery,n o .
7, pp. 632–637, 2006.
[25] S. C. Rao, G. G. Dove, G. D. Cascino, and R. C. Petersen,
“Recurrent seizures in patients with dementia: frequency,
seizure types, and treatment outcome,” Epilepsy and Behavior,
vol. 14, no. 1, pp. 118–120, 2009.
[26] A. J. Larner, “Epileptic seizures in AD patients,” NeuroMolecu-
lar Medicine, vol. 12, no. 1, pp. 71–77, 2010.